S tress myocardial perfusion imaging (MPI) has been proposed as an important gatekeeper for invasive coronary angiography (ICA) and percutaneous coronary interventions (PCI) in patients evaluated for hemodynamically significant coronary artery disease (CAD). MPI can be performed by single-photon emission computed tomography (SPECT), echocardiography, MRI, positron emission tomography (PET), and computed tomography (CT).
Diagnostic Accuracy of Stress MPI to ICA With FFR
have demonstrated that an FFR≤0.75 reliably identifies inducible myocardial ischemia, whereas an FFR of >0.80 reliably excludes myocardial ischemia. 2, 3 Benefits of FFR over other quantifiers of hemodynamically significant CAD are that it is unaffected by fluctuations in heart rate, blood pressure, and myocardial contractility. 4, 5 This meta-analysis aimed to determine the diagnostic accuracy of MPI compared with ICA with FFR for the diagnosis of hemodynamically significant CAD in patients with suspected or known CAD. Because an accurate and consistent reference standard is essential for a reliable comparison of the different MPI techniques, only studies using FFR as the reference standard were considered.
Methods
This meta-analysis was conducted in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. 6 The protocol was published in the PROSPERO database (www.crd.york.ac.uk/PROSPERO; PROSPERO 2014:CRD42014008737). Using predefined search criteria PubMed, EMBASE, and Web of Science were systematically searched from inception to May 2014. The search syntax is presented in Table 1 . No search restrictions were applied. A manual reference check of included articles was performed to identify potential studies missed by our search strategy.
Eligibility Criteria
Two independent reviewers used predefined criteria to determine article eligibility. Relevant articles were included based on the following criteria: study domain-patients with suspected or known CAD; index test-MPI SPECT, echocardiography, MRI, PET, and CT; reference standard-FFR for intermediate coronary lesions as defined by the individual studies; study results-agreement between index and reference standard; study design-cross-sectional study. When studies stemmed from overlapping populations, the study with the largest population was included. Discordances between reviewers were resolved by consensus discussion. Probability-adjusted agreement (κ statistic) evaluated inter-rater agreement. Animal studies, phantom studies, and case-reports (n<10) were excluded.
Critical Appraisal
Two independent reviewers assessed the relevance and validity of the included studies using the revised Quality Assessment of Studies of Diagnostic Accuracy Included in Systematic Reviews criteria. 7 The item blinding was presented separately to stress its relevance. The term flow and timing described the time interval between index test and reference standard and a period of ≤30 days was rated positive. Probability-adjusted agreement (κ statistic) was used to evaluate inter-rater agreement. Discrepancies were resolved by consensus discussion.
Data Extraction
Data extraction was performed by one reviewer (R.A.P.T.) and subsequently verified by a second reviewer (B.A.B.). The following data categories were extracted from the included studies: patient characteristics, stressor used for index test, index test characteristics, and FFR threshold. True positive, false-positive, false-negative, and true negative numbers were extracted. The findings were summarized in 2 by 2 contingency tables. Empty cells were filled with 0.5 events to allow the calculation of the outcome measures of interest. In case of multiple techniques/thresholds, the predefined primary end point was chosen. If the primary end point was not reported, the best performing technique/threshold parameter was chosen.
Data Synthesis and Analysis
All analyses were performed at both the vessel and the patient level. For each study, the sensitivity, specificity, positive and negative likelihood ratio (NLR), and the diagnostic odds ratio, along with the 95% confidence interval (CI), were calculated to express the diagnostic accuracy of the MPI techniques in diagnosing hemodynamically significant CAD when compared with ICA with FFR. Because methodological heterogeneity between included studies was anticipated, a random-effects (DerSimonian and Laird) model was used for pooling the data. 8 Per MPI technique, post-test probabilities were calculated based on various pretest probabilities and the pooled likelihood ratio. Also, pooled results were used to determine the area under the receiver operating characteristic curve and the Q* statistic. Assuming that MPI can act as a gatekeeper for PCI, ruling out hemodynamically significant CAD is the most important. Therefore, the NLR was chosen as the most important diagnostic test characteristic. Heterogeneity among study result was quantified by calculating the I 2 statistic. The degree of heterogeneity was considered low (I 2 <50%), moderate (I 2 =50%-75%), or high (I 2 >75%). 9 Per imaging technique, possible publication bias was assed graphically by drawing funnel plots and statistically via the Egger test for funnel plot asymmetry. 10 Statistical analysis was performed using R version 2.10.2 combined with the package meta, version 3.5-0 (R Foundation for Statistical Computing, Vienna, Austria) and the dedicated meta-analysis software Meta-DiSc version 1.4 (Universidad Complutense, Madrid, Spain). 11
Results
After exclusion of duplicates, the systematic search retrieved 488 potentially relevant articles ( Figure 1 ). Thirty-seven articles (excluding 4 with overlapping patient populations) [12] [13] [14] [15] met our predefined criteria and were selected for inclusion with an inter-rater agreement of κ=0.89. Included studies were published between 1996 and 2014. Population characteristics ( Table I in Overall, studies rated poorly on the item blinding the index test result from the assessor of the reference standard and standardized selection of the study population ( Figure 2 ).
Pooled Diagnostic Accuracy
For MRI, PET, and CT, pooled estimates of diagnostic accuracy (including sensitivity and specificity) were substantially higher when compared with SPECT or echocardiography (Tables 2 and   Table 1 3) . This finding was observed at both the vessel and the patient level. The summary receiver operating characteristic curve also demonstrated superior diagnostic accuracy for MRI, PET, and CT when compared with SPECT at the vessel ( Figure 3A ) and SPECT and echocardiography at patient level ( Figure 3B ). In line with these findings, a large change in post-test probability was observed for MRI, PET, and CT, whereas a modest change in post-test probability was observed for SPECT and echocardiography ( Figure 4 ; Table VII in the Data Supplement). 
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Discussion
This meta-analysis provides an overview of various noninvasive MPI techniques to diagnose hemodynamically significant CAD and found that MRI, PET, and CT are accurate in ruling out hemodynamically significant CAD in patients with suspected or known CAD. Therefore, MPI with MRI, CT, or PET has the potential to serve as a gatekeeper for invasive assessment of hemodynamic significance by ICA and FFR. Compared with CT and PET, MRI can determine myocardial blood flow without exposure to ionizing radiation. Furthermore, MRI, together with PET, allows absolute quantification of myocardial blood flow, which is important to detect perfusion defects in patients with 3-vessel disease. 16, 17 Hence, MRI combines high accuracy with low risk and could be considered as the method of choice to noninvasively rule out hemodynamically significant CAD in patients with chest pain syndromes.
During the past decade, the treatment of CAD has radically changed. Studies such as Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) and Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) initiated a shift from PCI as the treatment of choice based on anatomic CAD to a more nuanced use of PCI guided by the hemodynamic significance of CAD and by recognizing that optimal medical therapy is equal or favorable in many patients with CAD. 18, 19 Furthermore, FAME demonstrated that the routine measurement of FFR results in significantly reduced mortality and myocardial infarction rates at 2 years of follow-up in patients with multivessel CAD undergoing PCI with drug eluting stents. 18 Noninvasive assessment of hemodynamic CAD with stress MPI may further benefit patient outcome and costs.
A previously published meta-analysis compared stress MPI with MRI, PET, and SPECT to ICA without FFR and reported similar diagnostic accuracy, in terms of pooled sensitivity and specificity, at the patient level for PET (sensitivity, 0.84; 95% CI, 0.81-0.87; specificity, 0.81; 95% CI, 0.74-0.87). However, it reported lower accuracy for MRI (sensitivity, 0.89; 95% CI, 0.88-0.91; specificity, 0.76; 95% CI, 0.73-0.78) and reported higher sensitivity for SPECT (sensitivity, 0.88; 95% CI, 0.88-0.89; specificity, 0.61; 95% CI, 0.59-0.62) compared with our results. 20 95% confidence interval in parentheses. AUC indicates area under the receiver operating characteristic curve; CT, computed tomography; DOR, diagnostic odds ratio; FN, false-negative; FP, false-positive; NLR, negative likelihood ratio; PET, positron emission tomography; PLR, positive likelihood ratio; TN, true negative; TP, true positive; and SPECT, single-photon emission computed tomography. Diagnostic Accuracy of Stress MPI to ICA With FFR These differences may be because of the use of an anatomic reference standard instead of a hemodynamic reference standard.
The pooled results of our meta-analysis need to be considered in the context of the included studies, which were limited in number for some modalities. Although many more studies have compared MPI with ICA, most of these were noneligible because they did not perform FFR as reference standard. However, we considered any comparison with anatomic CAD by ICA as inappropriate because ICA alone has poor diagnostic performance for intermediate coronary stenoses and the decision to perform a PCI based on hemodynamic significance improves patient outcomes. 18, 21, 22 Moreover, recent evidence demonstrates that FFR has a continuous and independent relationship with subsequent major adverse cardiac events and lower FFR values benefit more from revascularization. 23 However, there is an ongoing discussion on the true reference standard for the measurement of myocardial ischemia. Although this problem remains unresolved, an answer will be provided by outcome data as obtained in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial (ClinicalTrials.gov Identifier: NCT01471522).
Significant in-between study heterogeneity was observed for CT, PET, and SPECT. Differences in study methodology, including hardware, acquisition protocols, stress protocols, and differences in the time interval between index and reference standard, likely account for this observation. Furthermore, the subjective nature of visual and semiquantitative assessment of MPI and imaging artifacts could result in an in-between study heterogeneity. Discrepancies in referral patterns and clinical thresholds for noninvasive perfusion imaging, reflected by the heterogeneity in prevalence of hemodynamically significant CAD among included studies ranging between 19% and 61% and 20% and 77% on a per-vessel and per-patient basis, respectively, are another potential source of an in-between study heterogeneity. Although substantial in-between study heterogeneity was observed among included studies for most MPI techniques, the random-effects model provided an accurate summary diagnostic accuracy estimate largely unachievable by standalone studies. 24 Therefore, the calculated pooled estimates of diagnostic accuracy provided ample information to decide on the technique of preference for noninvasive evaluation of hemodynamically significant CAD.
An important finding of this meta-analysis is that several noninvasive diagnostic tests can be used to select patients accurately whom do not benefit from coronary revascularization. The clinical use of the different techniques was evaluated using the average pretest probability for hemodynamically significant . The post-test probability given a negative test result was reduced to 9% to 11% for MRI, PET, and CT. Hence, a negative MRI, PET, and CT decreases the probability of disease by ≥35%. In case of a positive result, MRI and PET performed best with a post-test probability of hemodynamically significant CAD of 84% to 85%. Apart from the diagnostic performance per se, however, several other considerations are relevant to decide which test to use in clinical practice, such as availability, costs, and exposure to ionizing radiation. Radiation exposure is an important issue to consider when using SPECT, PET, and CT. Nevertheless, efforts such as iterative reconstruction algorithms combined with improvements in imaging hardware continue to reduce the radiation exposure of such imaging techniques. Also the use of 99m Tc (effective dose, 5.0-20.3 mSv) for SPECT examinations compared with short-lived radioisotope, such as 15 O-water (effective dose, 0.7-1.4 mSv), for PET, allow for reduced radiation dosages. 4, 5, 25 Moreover, high-quality anatomic information is not compulsory for PET MPI, reducing the radiation dosage from coregistered CT images. MRI does not expose patients to ionizing radiation. However, MRI cannot be performed in patients with iatrogenic devices, which are incompatible with the MRI environment. Nonetheless, the benefits of MPI still exceed the harmful effects of radiation exposure in patients considered for invasive revascularization.
An important strength of the present meta-analysis is that we compared all commonly used MPI techniques with FFR as a reference standard for the evaluation of intermediate stenosis. Our meta-analysis had several limitations. First, the meta-analysis focused on the diagnostic performance of MPI as a standalone technique. As such, we did not evaluate the added value of other diagnostic factors, such as age, sex, ventricular function, or stenosis degree. Combining multiple diagnostic variables could possibly yield even higher diagnostic accuracy in case of MRI and CT techniques. Second, it is unclear whether all stenoses were evaluated by FFR and studies used different FFR thresholds to define an intermediate anatomic stenosis. This is important because low-grade anatomic stenoses can be associated with a pathological FFR. 26 Third, the results are likely affected by expert center bias because most studies included were conducted at experienced imaging centers. Expert center bias could overestimate the diagnostic accuracy of the index test. Fourth, we observed broad confidence intervals. The width of the confidence interval depends on the precision of individual study estimates and on the total number of pooled vessels/patients. On the basis of randomeffects model, the confidence interval increases accordingly with an increase in in-between study heterogeneity. Because of the limited number of studies, determining the effect of an in-between study heterogeneity (including differences in patient demographics, differences in pretest probability of CAD, and differences in imaging technology) by meta-regression techniques could not be performed. Nonetheless, eyeballing of Tables IV and V in the Data Supplement revealed no obvious correlation between publication year and diagnostic accuracy of MPI techniques with large in-between study heterogeneity. Therefore, it seems unlikely that advances in imaging technology account for the observed in-between study heterogeneity. Fifth, studies evaluating the performance of echocardiography were based on a different classification of ischemia, namely wall motion abnormalities.
Because wall motion abnormalities occur later in the ischemic cascade, echocardiography should be less sensitive, but more specific when compared with other MPI techniques. Finally, only studies using ICA with FFR as the reference standard were eligible for inclusion. Therefore, only 3 PET studies (all using 15 O-water) met the inclusion criteria, with substantial differences in diagnostic accuracy, resulting in high in-between study heterogeneity on both per-vessel and per-patient level. Because of the short half-life (≈2 minutes) of 15 O-water, the production of this PET-tracer requires an onsite cyclotron. As a result, most PET MPI examinations are performed with 82 Rb-chloride instead. 82 Rb-chloride has less favorable flow-extraction characteristics compared with 15 O-water. Therefore, it is not possible to extrapolate the findings from 15O-water PET studies to clinical settings in which 82 Rb-chloride is used. No studies evaluated the use of 82 Rb-chloride compared with FFR for intermediate stenoses.
Conclusions
The presence of hemodynamically significant CAD can be accurately ruled out by stress MPI with MRI, CT, or PET, but less accurate with SPECT or echocardiography when compared with invasive FFR. Therefore, MPI with MRI, CT, or PET can act as an important gatekeeper for ICA and PCI. Considering the merits and shortcomings of the different noninvasive techniques, MRI could be regarded as the technique of choice because it does not involve exposure to ionizing radiation and achieves similar diagnostic performance compared with PET and CT. In contrast, the more widely available SPECT and echocardiography imaging techniques are less suited for excluding hemodynamically significant CAD.
